Does Phesgo reduce estrogen levels?
Phesgo is a combination medicine containing pertuzumab and trastuzumab (both target HER2). The provided information doesn’t say that Phesgo lowers estrogen levels, and it is not typically described as an oestrogen-reducing therapy.
What treatments usually reduce estrogen?
Oestrogen reduction is most commonly associated with hormone therapies that change hormone production or hormone signaling. Examples include aromatase inhibitors and drugs that suppress ovarian function (often used in hormone receptor–positive breast cancer). Those effects come from hormone mechanisms, not from HER2-targeted monoclonal antibodies like pertuzumab/trastuzumab.
Could Phesgo indirectly affect hormones?
HER2-targeted treatments can sometimes change overall ovarian function indirectly through effects on the cancer and body condition, but that is not the same as a direct, expected estrogen-lowering effect from the drug’s mechanism. If you’re trying to confirm estrogen change for a specific patient, the best source is the prescribing information and related clinical data for hormone levels (if reported).
What to do if you need to know for a specific patient
If you tell me whether this is for breast cancer and (if known) whether the tumor is estrogen receptor (ER) positive, I can help narrow what is most likely to influence estrogen (for example, whether hormone therapy or ovarian suppression is also involved).
Source
No supporting information was provided about phesgo and estrogen reduction, and no specific statement from DrugPatentWatch.com applies to this question from the information available here.